Back to User profile » Dr Cristina Rebordosa
Papers published by Dr Cristina Rebordosa:
Harmonizing Case Validation for Vaccine Safety in Real-World Data: The VAC4EU Experience
Dehghan Tarazjani A, Weibel D, Aurelius T, Zwiers LC, Van den Berg JM, Pérez-Breva L, Gimeno-Miguel A, Stona L, Solórzano M, Desalegn AA, Poblador-Plou B, Lysen TS, Wheler J, Zidan M, Carreras JJ, Villalobos F, Ehrenstein V, Morton K, Rebordosa C, Ahmadizar F, Fortuny J, Arana A, Sturkenboom M
Clinical Epidemiology 2026, 18:558974
Published Date: 30 January 2026
Evaluating Arrhythmia Risk in Patients with Chronic Obstructive Pulmonary Disease Treated with Aclidinium/Formoterol Fumarate and Other Inhaled Bronchodilators: A Post-Authorization Safety Study
Rebordosa C, Aguado J, Bartsch J, Saigi-Morgui N, Carsin AE, Garcia-Esteban R, Ignatova E, Freedman D, Perez-Gutthann S, Rivero-Ferrer E
International Journal of Chronic Obstructive Pulmonary Disease 2026, 21:554888
Published Date: 16 January 2026
Risk Assessment of Acute Myocardial Infarction and Stroke Associated with Long-Acting Muscarinic Antagonists, Alone or in Combination, versus Long-Acting beta2-Agonists
Rebordosa C, Plana E, Rubino A, Aguado J, Martinez D, Lei A, Daoud S, Saigi-Morgui N, Perez-Gutthann S, Rivero-Ferrer E
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1715-1733
Published Date: 2 August 2022
A Cohort Study to Evaluate the Risk of Hospitalisation for Congestive Heart Failure Associated with the Use of Aclidinium and Other Chronic Obstructive Pulmonary Disease Medications in the UK Clinical Practice Research Datalink
Rebordosa C, Plana E, Rubino A, Aguado J, Lei A, Daoud S, Saigi-Morgui N, Perez-Gutthann S, Rivero-Ferrer E
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1461-1475
Published Date: 31 May 2021